Study of TNF-α, IL-1β and LPS levels in the gingival crevicular fluid of a rat model of diabetes mellitus and periodontitis

Disease Markers

Volumn 34, Issue 5, 2013, Pages 295-304

  Jiang, Zhu Ling ^a   Cui, Yu Qiong ^a   Gao, Rui ^a   Li, Ying ^a   Fu, Zhao Chen ^a   Zhang, Bin ^a   Guan, Cheng Chao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

alveolar bone loss; diabetes mellitus; GCF; histopathology; IL 1 ; LPS; periodontitis; TNF

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GINGIVITIS; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

RATTUS;

EID: 84878826031     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-130974     Document Type: Article

References (41)

1. Pontes Andersen CC, Flyvbjerg A, Buschard K, Holmstrup P, Relationship between periodontitis and diabetes: lessons from rodent studies, J Periodontol (2007), 78: 1264-1275.
2. Taylor GW, Borgnakke WS, Periodontal disease: Associations with diabetes, glycemic control and complications, Oral Dis (2008), 14: 191-203.
3. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y, Periodontal disease and diabetes mellitus: The role of tumor necrosis factor-alpha in a 2-way relationship, J Periodontol (2003), 74: 97-102.
4. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance, Science (1996), 271: 665-668.
5. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M, Relationship between serum tumor necrosis factoralpha and insulin resistance in obese men with Type 2 diabetes mellitus, Diabetes Res Clin Pract (2001), 52: 119-123.
6. Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Peñarroja G, Broch M, Pérez A, Richart C, Engel P, Ricart W, Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus, Am J Physiol Endocrinol Metab (2002), 282: E952-959.
7. Lechleitner M, Herold M, Dzien-Bischinger C, Hoppichler F, Dzien A, Tumour necrosis factor-alpha plasma levels in elderly patients with Type 2 diabetes mellitus-observations over 2 years, Diabet Med (2002), 19: 949-953.
8. Bretz WA, Weyant RJ, Corby PM, Ren D, Weissfeld L, Kritchevsky SB, Harris T, Kurella M, Satterfield S, Visser M, Newman AB, Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population, J Am Geriatr Soc (2005), 53: 1532-1537.
9. Salvi GE, Beck JD, Offenbacher S, PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression, Ann Periodontol (1998), 3: 40-50.
10. Teles R, Sakellari D, Teles F, Konstantinidis A, Kent R, Socransky S, Haffajee A, Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota, J Periodontol (2010), 81: 89-98.
11. Cetinkaya B, Guzeldemir E, Ogus E, Bulut S, Pro-and Antiinflammatory Cytokines in Gingival Crevicular Fluid and Serum of Rheumatoid Arthritis and Chronic Periodontitis Patients, J Periodontol 2012 Mar 13. [Epub ahead of print].
12. Ryan ME, Carnu O, Kamer A, The influence of diabetes on the periodontal tissues, J Am Dent Assoc (2003), 134: 34S-40S.
13. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S, Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases, J Clin Periodontol (1997), 24: 8-16.
14. Akira S, Hemmi H, Recognition of pathogen-associated molecular patterns by TLR family, Immunol Lett (2003), 85: 85-95.
15. Jill E. Rogers, Fei Li, Derek D. Coatney, Actinobacillus actinomycetemcomitans Lipopolysaccharide-Mediated Experimental Bone Loss Model for Aggressive Periodontitis, J Periodontol (2007), 78: 550-558.
16. Hersh D, Weiss J, Zychlinsky A, How bacteria initiate inflammation: Aspects of the emerging story, Curr Opin Microbiol (1998), 1: 43-48.
17. K. Srinivasan, B. Viswanad, Lydia Asrat, C. L. Kaul, P. Ramarao, Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening, Pharmacological Research (2005), 52: 313-320.
18. Ti Y, Xie GL, Wang ZH, Bi XL, Ding WY, Wang J, Jiang GH, Bu PL, Zhang Y, Zhong M, ZhangW, TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model, Diabetes (2011), 60: 2963-2974.
19. Semenoff Segundo A, Semenoff TA, Borges AH, Pedro FL, Sakai VT, Methodological model of chronic stress associated with ligature-induced periodontitis in rats: a radiographic study, Braz Oral Res (2010), 24: 455-459.
20. Semenoff TADV, Semenoff-Segundo A, Bosco AF, Nagata MJ, Garcia VG, Biasoli ER, Histometric analysis of ligatureinduced periodontitis in rats: A comparison of histological section planes, J Appl Oral Sci (2008), 16: 251-256.
21. Souza DM, Rocha RF, Low caloric value of ethanol itself increases alveolar bone loss in ligature-induced periodontitis in male rats, Bras Oral Res (2009), 23: 460-466.
22. Lamster IB, Oshrain RL, Celenti R, Levine K, Fine JB, Correlation analysis for clinical and gingival crevicular fluid parameters at anatomically related gingival sites, J Clin Periodontol (1991), 18: 272-277.
23. Hagai Hazan-Molina, Abraham Z. Reznick, Hanna Kaufman, Dror Aizenbud, Assessment of IL-1? and VEGF concentration in a rat model during orthodontic tooth movement and extracorporeal shock wave therapy, Archives of Oral Biology 2012 October 22, [Epub ahead of print].
24. Lalla E, Lamster IB, FeitM, Huang L, Schmidt AM, A murine model of accelerated periodontal disease in diabetes, J Periodontal Res (1998), 33: 387-399.
25. de Lima V, Bezerra MM, de Menezes Alencar VB, Vidal FD, da Rocha FA, de Castro Brito GA, de Albuquerque Ribeiro R, Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats, Eur J Oral Sci (2000), 108: 123-129.
26. Carvalho RS, de Souza CM, Neves JC, Holanda-Pinto SA, Pinto LM, Brito GA, de Andrade GM, Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats, J Negat Results Biomed (2010), 9: 3.
27. Leitão RF, Ribeiro RA, Chaves HV, Rocha FA, Lima V, Brito GA, Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats, J Periodontol (2005), 76: 956-963.
28. Steven Offenbacher, DDs, PhD, MMSC, 1 Silvana Barros, DDS, PhD, 1 L Mendoza, DDS, S Mauriello, MS, J Preisser, PhD, K Moss, Marko de Jager, PhD, MMSc, 2 and Marcelo Aspiras, PhD2, Changes in Gingival Crevicular Fluid Inflammatory Mediator Levels during the Induction and Resolution of Experimental Gingivitis in Humans, J Clin Periodontol (2010), 37: 324-333.
29. Heasman PA, Collins JG, Offenbacher S, Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans, J Periodontal Res (1993), 28: 241-247.
30. Beutler BA, Milsark IW, Cerami A, Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo, J Immunol (1985), 135: 3972-3977.
31. Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, Bonvillain RW, Lasky JA, Bunnell BA, Welsh DA, Prockop DJ, Sullivan DE, Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-?-induced protein 6, Stem Cell Res Ther (2011), 2: 27.
32. Bretz WA, Weyant RJ, Corby PM, Ren D, Weissfeld L, Kritchevsky SB, Harris T, Kurella M, Satterfield S, Visser M, Newman AB, Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population, J Am Geriatr Soc (2005), 53: 1532-1537.
33. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF, Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study, Diabetes (2003), 52: 812-817.
34. Orbak R, Tezel A, Canakçi V, Demir T, The influence of smoking and non-insulin-dependent diabetes mellitus on periodontal disease, J Int Med Res (2002), 30: 116-125.
35. Tracey K, Cerami A, Metabolic responses to cachectin/TNF, Annals of the New York academy of sciences (1990), 587: 325-331.
36. Lalla E, Cheng B, Lal S, Kaplan S, Softness B, Greenberg E, Goland RS, Lamster IB, Diabetes mellitus promotes periodontal destruction in children, J Clin Periodontol (2007), 34: 294-298.
37. Mishima N, Sahara N, Shirakawa M, Ozawa H, Effect of streptozotocin- induced diabetes mellitus on alveolar bone deposition in the rat, Arch Oral Biol (2002), 47: 843-849.
38. Villarino ME, Sánchez LM, Bozal CB, Ubios AM, Influence of short-term diabetes on osteocytic lacunae of alveolar bone. A histomorphometric study, Acta Odontol Latinoam (2006), 19: 23-28.
39. Santos Tunes R, Foss-Freitas MC, Nogueira-Filho Gda R, Impact of periodontitis on the diabetes-related inflammatory status, J Can Dent Assoc (2010), 76: a35.
40. Nassar H, Kantarci A, van Dyke TE: Diabetic periodontitis, a model for activated innate immunity and impaired resolution of inflammation, Periodontol 2000 (2007), 43: 233-244.
41. Akira S, Takeda K, Toll-like receptor signalling, Nat Rev Immunol (2004), 4: 499-511.